$TER

JOHNSON MERCEDES sold $77K of TER

JOHNSON MERCEDES sold 167 shares of TERADYNE, INC (TER) at $460.00 on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · JOHNSON MERCEDES
Published Jul 2, 2026, 5:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 5:18 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TER
Neutral
high confidence
Mentioned
$TER
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TERNeutralLow
01

Why it matters

The disclosed event is an open-market sale by a director under a pre-arranged 10b5-1 plan; it typically has limited directional implications for the stock.

02

Market read

Traders may log the transaction for insider-flow monitoring, but there is no new company-specific catalyst (no guidance, deal, or regulatory action).

03

What to watch

The filing does not disclose reasons for sale beyond the plan; the small dollar amount reduces signal-to-noise versus larger insider transactions.

Relevance 2/10Novelty 3/10Timing: New SEC Form 4 filed 2026-07-02 (sale dated 2026-07-01).

Background

The article is an SEC Form 4 insider transaction disclosure for Teradyne, Inc.

Company-level read

Ticker impact

$TERNeutralHigh confidence
Context

Teradyne director Johnson Mercedes sold 167 shares at $460 on 2026-07-01 under a pre-arranged 10b5-1 plan, per Form 4.

Expected impact

Minimal impact; any reaction is likely noise unless followed by additional, larger insider actions.

Evidence & confidence

The filing is a routine open-market sale with a stated 10b5-1 plan and modest share count/value, providing limited incremental information.

Market effects

No sector read-through; this is a single-insider transaction with no operational or guidance change.

None indicated.

None indicated.

Counterpoint

Even 10b5-1 sales can coincide with private information, so traders may watch for clustering of insider sales around the same period.

Key entities

  • TERADYNE, INC

    Company whose insider transaction is disclosed on SEC Form 4.

  • JOHNSON MERCEDES

    Director who sold 167 shares at $460/share under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FORMMedAI 8/10

FormFactor, Entegris, Penguin Solutions, Teradyne, and Marvell Technology Stocks Trade Up, What You Need To Know

Several semiconductor stocks rose after the August jobs report, which showed 162,000 nonfarm payroll jobs added, beating estimates. Despite initial expectations of a rate hike, traders rotated back into the chip sector. FormFactor (FORM) +5.3%, Entegris (ENTG) +5.6%, Penguin Solutions (PENG) +5.1%, Teradyne (TER) +4.8%, and Marvell Technology (MRVL) +6.2%. Marvell reported Q2 revenue of $2.74B, up 36.5% YoY, with strong Data Center demand. Management guided Q3 revenue at $3.15B, but revenue from

$TERMed

Teradyne Stock Plunges 15% in a Month: Should You Buy the Dip?

Teradyne (TER) shares fell 15.4% in a month, underperforming peers and sector. Challenges include customer concentration and muted demand, but AI-driven data center growth and strong Q3 guidance offset this. TER expects $1.20-$1.30B revenue and $1.85-$2.15 EPS for Q3 2026, up significantly YoY. The stock trades at a premium with a forward P/S of 9.35X.

$TERHigh

Why is Teradyne stock sliding today?

Teradyne (TER) stock fell 3.9% after Baird downgraded it to Neutral with a $420 price target, citing stretched valuation and concerns over AI and hyperscaler spending sustainability. The firm argues GPU testing catalyst is priced in and next growth drivers are too distant. TER's decline contrasts with broader market gains, highlighting company-specific pressures.

$METAMed

Stocks making the biggest moves midday: Meta, Amylyx, Baidu, Klarna, Coherent, Sandisk & more

Amylyx Pharmaceuticals shares rose 53% after its avexitide treatment met trial endpoints. Meta Platforms fell 3% amid a lawsuit. Carvana dropped 3% after director stock sales. UGI Corporation surged 12% on a $9B KKR bid report. AI-related stocks declined. Klarna fell 21% on weak guidance. Baidu dropped 12% on earnings miss. Home Depot rose slightly on earnings beat. Fabrinet fell 20% on margin concerns. Memory stocks declined. Duolingo rose 7% on an upgrade.